FDA’s Califf shares priority list with agency staff
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyComplianceHealth Authority meeting and communication strategyMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy